ライフサイエンスコーパス: reentrant tachycardia

1 dal reentry tachycardia and atrioventricular reentrant tachycardia).

2 ent symptomatic episodes of atrioventricular reentrant tachycardia.

3 substantiated by induction of orthodromic AV reentrant tachycardia.

4 give rise to localized reentry and AV nodal reentrant tachycardia.

5 f adenosine in patients with typical AV node reentrant tachycardia.

6 dose adenosine led to initiation of AV node reentrant tachycardia.

7 occurred in 13 of 139 patients with AV node reentrant tachycardia.

8 herapeutic approach in patients with AV node reentrant tachycardia.

9 tor for understanding common arrhythmias and reentrant tachycardia.

10 complexes, and orthodromic atrioventricular reentrant tachycardia.

11 al flutters (n=2) and atrioventricular nodal reentrant tachycardia.

12 ; PPI-TCL) is a useful tool in mapping macro-reentrant tachycardias.

13 sthmus is the critical element of perimitral reentrant tachycardias.

14 reentry tachycardia [2] and atrioventricular reentrant tachycardia [1]).

15 rrence, including sustained atrioventricular reentrant tachycardia (132 patients) or atrial fibrillat

16 rhythmia substrates (80% non-CTI intraatrial reentrant tachycardia, 40% focal atrial tachycardia).

17 l reentrant tachycardia (non-CTI intraatrial reentrant tachycardia, 53%) and focal atrial tachycardia

18 f initial episodes of atrioventricular nodal reentrant tachycardia (95% confidence interval 21% to 67

19 Intraatrial reentrant tachycardias, a common late complication of at

20 AV nodal reentrant tachycardia ablation also required transbaffle

21 rhythmias, and 4 patients underwent AV nodal reentrant tachycardia ablation.

22 dual AV node physiology and typical AV node reentrant tachycardia and 10 control patients were given

23 ents with CHD who had atrioventricular nodal reentrant tachycardia and were treated with catheter abl

24 s, atrial tachycardia, atrioventricular node reentrant tachycardia) are significant predominantly bec

25 ral isthmus is a critical part of perimitral reentrant tachycardia, as well as an important substrate

26 7 years) underwent ablation for non-AV nodal reentrant tachycardia atrial arrhythmias, and 4 patients

27 doxically AH(SVT)<AH(NSR), differentiates NF reentrant tachycardia/atrioventricular nodal reentrant t

28 of junctional reciprocating tachycardia, NF reentrant tachycardia/atrioventricular nodal reentrant t

29 loci associated with atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular acces

30 nce, data on atypical atrioventricular nodal reentrant tachycardia (AVNRT) are scarce, and the optima

31 ulmonary veins (PVs), atrioventricular nodal reentrant tachycardia (AVNRT) can also cause or coexist

32 Atrioventricular nodal reentrant tachycardia (AVNRT) is considered a sporadic d

33 r patients with the typical form of AV nodal reentrant tachycardia (AVNRT) underwent selective radiof

34 th atrial flutter and atrioventricular nodal reentrant tachycardia (AVNRT) who underwent fluoroscopic

35 pathways serve as the substrate for AV node reentrant tachycardia (AVNRT), ablation of the slow path

36 undergone ablation of atrioventricular nodal reentrant tachycardia (AVNRT), an accessory pathway (AP)

37 eatment of choice for atrioventricular nodal reentrant tachycardia (AVNRT).

38 thetic stimulation in patients with AV nodal reentrant tachycardia (AVNRT).

39 and 53 patients without AP who had AV nodal reentrant tachycardia (AVNRT).

40 sk of PSVT, and thus likely atrioventricular reentrant tachycardia, but had allele-specific associati

41 Atrioventricular nodal reentrant tachycardia can complicate the course of patie

42 Successful ablation of intra-atrial reentrant tachycardia complicating surgery for congenita

43 en consecutive patients with 26 intra-atrial reentrant tachycardias complicating surgery for congenit

44 cating tachycardia or atrioventricular nodal reentrant tachycardia), excluding Wolff-Parkinson-White,

45 able OHT patients can be attributed to macro-reentrant tachycardias (flutter and scar reentry).

46 7% to 99%) have remained free of intraatrial reentrant tachycardia for a mean of 7.5 +/- 5.3 months.

47 reentrant tachycardia/atrioventricular nodal reentrant tachycardia from permanent form of junctional

48 Seven patients with AV node reentrant tachycardia had evidence of a posterior fast p

49 reentrant tachycardia/atrioventricular nodal reentrant tachycardia had longer AH (29 ms versus 10 ms;

50 th dual AV node pathways and typical AV node reentrant tachycardia has not previously been studied.

51 ent decades in curing atrioventricular nodal reentrant tachycardias has intensified efforts to provid

52 fferent types of atrioventricular (AV) nodal reentrant tachycardia have not yet been elucidated.

53 Although symptomatic atrial reentrant tachycardias have a female predominance, the r

54 Intra-atrial reentrant tachycardia (IART) after the Fontan operation

55 possible factors for inducible intra-atrial reentrant tachycardia (IART) in a group of patients afte

56 Intraatrial reentrant tachycardia (IART) is a common problem in pati

57 rs of congenital heart surgery, intra-atrial reentrant tachycardia (IART) often develops.

58 Intraatrial reentrant tachycardia (IART), a difficult arrhythmia to

59 ion sites remains difficult for intra-atrial reentrant tachycardias (IART) in congenital heart diseas

60 duced in 27 of 30 patients; atrioventricular reentrant tachycardia in 25 (93%) of 27 and intraatrial

61 The increase in AV node reentrant tachycardia in adults may relate to changes in

62 literature on catheter ablation of AV nodal reentrant tachycardia in congenital heart disease, to pr

63 achycardia in 25 (93%) of 27 and intraatrial reentrant tachycardia in only 2 (7%) of 27.

64 We tested the hypotheses that intra-atrial reentrant tachycardia in patients who had undergone prio

65 er ablation for the treatment of intraatrial reentrant tachycardia in patients with previous atrial s

66 que for definitive management of intraatrial reentrant tachycardia in patients with previous atrial s

67 Acceleration of reentrant tachycardia induced by programmed electrical s

68 1 atrioventricular (AV) block during AV node reentrant tachycardia induced in the electrophysiology l

69 actory period (P<0.001) and atrioventricular reentrant tachycardia initiating atrial fibrillation (P<

70 Paroxysmal atrioventricular nodal reentrant tachycardia is an infrequently encountered sup

71 dence of induced 2:1 AV block during AV node reentrant tachycardia is approximately 10%.

72 Atrioventricular reentrant tachycardia is common in children.

73 l in blocked beats, 2:1 block during AV node reentrant tachycardia is due to functional infranodal bl

74 s observed in 6 (8%) of the atrioventricular reentrant tachycardia mediated by septal AP (P<0.001; se

75 ntricular nodal reentry and atrioventricular reentrant tachycardia mediated by septal APs.

76 , atrial tachycardia, atrioventricular nodal reentrant tachycardia, monomorphic ventricular tachycard

77 al reciprocating tachycardia; n=4] or NF [NF reentrant tachycardia; n=2]) accessory pathway underwent

78 tients, followed by scar-related intraatrial reentrant tachycardia (non-CTI intraatrial reentrant tac

79 Intra-atrial reentrant tachycardia occurs frequently after surgery fo

80 Intra-atrial reentrant tachycardia occurs in 10% to 40% of patients a

81 Compared with atrioventricular nodal reentrant tachycardia, ORT patients were younger (42+/-1

82 may underlie the acceleration of functional reentrant tachycardias paced by a clinician or an antita

83 rkinson-White patients with atrioventricular reentrant tachycardia referred for electrophysiological

84 N) electrophysiology in the treatment of AVN reentrant tachycardias rely on empirical findings, such

85 Atrioventricular (AV) nodal reentrant tachycardia represents the most common regular

86 (1.6%) ablations for atrioventricular nodal reentrant tachycardia resulted in atrioventricular block

87 Right atrial reentrant tachycardia resulting from lower loop reentry

88 factors makes catheter ablation of AV nodal reentrant tachycardia substrate particularly challenging

89 In patients with 2:1 AV block during AV node reentrant tachycardia, the absence of a His bundle poten

90 th dual AV node pathways and typical AV node reentrant tachycardia, the fast pathway is more sensitiv

91 In consecutive patients with AV node reentrant tachycardia, the incidence of 2:1 AV block and

92 The relationship of atrioventricular nodal reentrant tachycardia to congenital heart disease (CHD)

93 nversion of new-onset atrioventricular nodal reentrant tachycardia to sinus rhythm in critically ill

94 actory period (P<0.001) and atrioventricular reentrant tachycardia triggering sustained pre-excited a

95 ory pathways (P<0.001), and atrioventricular reentrant tachycardia triggering sustained pre-excited a

96 y of atrial surgery and clinical intraatrial reentrant tachycardia underwent electrophysiologic testi

97 admission to onset of atrioventricular nodal reentrant tachycardia was 4.5 +/- 5 days (median 2.5).

98 Atrioventricular reentrant tachycardia was the predominant mechanism of s

99 ith 20 SVTs (atypical atrioventricular nodal reentrant tachycardia without [n=11]/with [n=3] a bystan